These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7902726)

  • 1. Recovery of atracurium and vecuronium neuromuscular block in the isolated forearm.
    Min JC; Hood J; Campkin N; Feldman S
    Br J Anaesth; 1993 Nov; 71(5):730-1. PubMed ID: 7902726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of doxapram on the rate of recovery from atracurium and vecuronium neuromuscular block.
    Cooper R; McCarthy G; Mirakhur RK; Maddineni VR
    Br J Anaesth; 1992 May; 68(5):527-8. PubMed ID: 1353680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between atracurium and vecuronium in children.
    Meretoja OA; Brandom BW; Taivainen T; Jalkanen L
    Br J Anaesth; 1993 Sep; 71(3):440-2. PubMed ID: 8104448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat.
    Sutherland GA; Squire IB; Gibb AJ; Marshall IG
    Br J Anaesth; 1983 Nov; 55(11):1119-26. PubMed ID: 6139121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atracurium: neuromuscular blockade in repeated administration].
    Kube D; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):639-44. PubMed ID: 2869712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
    Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the power spectrum of the evoked compound action potential of the adductor pollicis with the onset of neuromuscular blockade.
    Harper NJ; Pugh ND; Healy TE; Petts HV
    Br J Anaesth; 1987 Feb; 59(2):200-5. PubMed ID: 2881566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the train-of-four fade profiles produced by vecuronium and atracurium.
    Fletcher JE; Sebel PS; Mick SA; Van Duys J; Ryan K
    Br J Anaesth; 1992 Feb; 68(2):207-8. PubMed ID: 1347231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative characteristics of atracurium and vecuronium. A simultaneous clinical and pharmacokinetic study.
    Wright PM; Hart P; Lau M; Sharma ML; Gruenke L; Fisher DM
    Anesthesiology; 1994 Jul; 81(1):59-68; discussion 27A. PubMed ID: 7913801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting train-of-four fade.
    Pearce AC; Casson WR; Jones RM
    Br J Anaesth; 1985 Jun; 57(6):602-6. PubMed ID: 2860913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of atracurium or vecuronium to prolong the action of tubocurarine.
    Middleton CM; Pollard BJ; Healy TE; Kay B
    Br J Anaesth; 1989 Jun; 62(6):659-63. PubMed ID: 2568848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atracurium and vecuronium on the latency and the duration of the negative deflection of the evoked compound action potential of the adductor pollicis.
    Pugh ND; Harper NJ; Healy TE; Petts HV
    Br J Anaesth; 1987 Feb; 59(2):195-9. PubMed ID: 2881565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients.
    Slavov V; Khalil M; Merle JC; Agostini MM; Ruggier R; Duvaldestin P
    Br J Anaesth; 1995 Jun; 74(6):709-11. PubMed ID: 7640130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending a pipecuronium neuromuscular block. Increments of atracurium or vecuronium as an alternative to pipecuronium.
    Roberts SP; Ramsay TM; Healy TE; Wilson A; Pollard BJ
    Anaesthesia; 1993 Mar; 48(3):196-9. PubMed ID: 8096370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.